Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.020
+0.095 (3.25%)
May 12, 2025, 4:00 PM - Market closed
Cytek Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 95.3 | 98.72 | 167.3 | 296.6 | 364.62 | 165.23 | Upgrade
|
| Short-Term Investments | 170.31 | 179.15 | 95.11 | 44.55 | - | - | Upgrade
|
| Cash & Short-Term Investments | 265.61 | 277.86 | 262.41 | 341.15 | 364.62 | 165.23 | Upgrade
|
| Cash Growth | -1.66% | 5.89% | -23.08% | -6.44% | 120.67% | 448.54% | Upgrade
|
| Accounts Receivable | 55.03 | 60.59 | 55.93 | 48.86 | 29.76 | 16.99 | Upgrade
|
| Other Receivables | 0.18 | - | 0.19 | 2.01 | -0.13 | 1.11 | Upgrade
|
| Receivables | 55.21 | 60.59 | 56.12 | 50.88 | 29.63 | 18.1 | Upgrade
|
| Inventory | 45.65 | 44.01 | 61.17 | 48.78 | 32.57 | 23.05 | Upgrade
|
| Prepaid Expenses | 4.37 | 4.64 | 3.99 | 4.45 | 4.21 | 0.91 | Upgrade
|
| Restricted Cash | - | 0.03 | 0.33 | 2.9 | - | 0.89 | Upgrade
|
| Other Current Assets | 9.67 | 9.32 | 8.04 | 5.88 | 0.71 | 0.45 | Upgrade
|
| Total Current Assets | 380.5 | 396.45 | 392.06 | 454.02 | 431.73 | 208.62 | Upgrade
|
| Property, Plant & Equipment | 27.7 | 28.13 | 29.26 | 27.57 | 5.85 | 2.14 | Upgrade
|
| Long-Term Investments | 1.6 | 1.6 | - | - | - | - | Upgrade
|
| Goodwill | 16.68 | 16.66 | 16.18 | 10.14 | 10.14 | 0.48 | Upgrade
|
| Other Intangible Assets | 19.43 | 20.13 | 23.08 | 4.33 | 4.74 | 0.27 | Upgrade
|
| Long-Term Deferred Tax Assets | 33.71 | 33.37 | 30.49 | 20.46 | 9.17 | 7.38 | Upgrade
|
| Other Long-Term Assets | 2.97 | 3.16 | 3.39 | 2.96 | 1.67 | 1.09 | Upgrade
|
| Total Assets | 482.6 | 499.5 | 494.46 | 519.48 | 463.31 | 219.98 | Upgrade
|
| Accounts Payable | 6.25 | 5.53 | 3.03 | 4.81 | 3.03 | 2.94 | Upgrade
|
| Accrued Expenses | 19.75 | 21.69 | 18.99 | 20.42 | 14.89 | 8.65 | Upgrade
|
| Short-Term Debt | 2.4 | 4.16 | - | - | - | 2.77 | Upgrade
|
| Current Portion of Long-Term Debt | 1.59 | 0.5 | 0.57 | 0.58 | - | - | Upgrade
|
| Current Portion of Leases | 3.54 | 3.76 | 2.44 | 2.93 | - | - | Upgrade
|
| Current Income Taxes Payable | 1.82 | 1.52 | 1.3 | 0.25 | 2.48 | 0.47 | Upgrade
|
| Current Unearned Revenue | 28.75 | 26.61 | 24.13 | 14.54 | 8.1 | 4.29 | Upgrade
|
| Other Current Liabilities | 3.59 | 3.9 | 5.76 | 5.52 | 4.68 | 7.42 | Upgrade
|
| Total Current Liabilities | 67.69 | 67.66 | 56.23 | 49.04 | 33.18 | 26.54 | Upgrade
|
| Long-Term Debt | 0.92 | 1.05 | 1.65 | 2.27 | - | - | Upgrade
|
| Long-Term Leases | 7.45 | 7.55 | 9.48 | 12.31 | - | - | Upgrade
|
| Long-Term Unearned Revenue | 15.72 | 16.1 | 15.13 | 13.12 | 9.79 | 3.46 | Upgrade
|
| Other Long-Term Liabilities | 11.2 | 11.4 | 18.91 | 17.18 | 14.95 | 11.7 | Upgrade
|
| Total Liabilities | 102.97 | 103.76 | 101.39 | 93.93 | 57.92 | 41.69 | Upgrade
|
| Common Stock | 0.13 | 0.13 | 0.13 | 0.14 | 0.13 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 426.71 | 430.79 | 423.39 | 442.89 | 423.63 | 6.49 | Upgrade
|
| Retained Earnings | -46.6 | -35.2 | -29.18 | -17.03 | -19.61 | -22.61 | Upgrade
|
| Comprehensive Income & Other | -0.61 | 0.02 | -1.28 | -0.7 | 0.9 | 0.07 | Upgrade
|
| Total Common Equity | 379.62 | 395.74 | 393.06 | 425.3 | 405.04 | -16.03 | Upgrade
|
| Minority Interest | - | - | - | 0.25 | 0.34 | - | Upgrade
|
| Shareholders' Equity | 379.62 | 395.74 | 393.06 | 425.55 | 405.39 | 178.29 | Upgrade
|
| Total Liabilities & Equity | 482.6 | 499.5 | 494.46 | 519.48 | 463.31 | 219.98 | Upgrade
|
| Total Debt | 15.9 | 17.02 | 14.14 | 18.09 | - | 2.77 | Upgrade
|
| Net Cash (Debt) | 249.72 | 260.85 | 248.27 | 323.06 | 364.62 | 162.46 | Upgrade
|
| Net Cash Growth | -2.34% | 5.06% | -23.15% | -11.40% | 124.44% | 439.34% | Upgrade
|
| Net Cash Per Share | 1.92 | 2.00 | 1.84 | 2.33 | 4.47 | 4.98 | Upgrade
|
| Filing Date Shares Outstanding | 126.66 | 128.1 | 130.82 | 135.43 | 134.08 | 31.24 | Upgrade
|
| Total Common Shares Outstanding | 127.6 | 129.21 | 130.71 | 135.37 | 133.75 | 31.24 | Upgrade
|
| Working Capital | 312.81 | 328.78 | 335.83 | 404.98 | 398.55 | 182.09 | Upgrade
|
| Book Value Per Share | 2.98 | 3.06 | 3.01 | 3.14 | 3.03 | -0.51 | Upgrade
|
| Tangible Book Value | 343.51 | 358.95 | 353.8 | 410.82 | 390.16 | -16.78 | Upgrade
|
| Tangible Book Value Per Share | 2.69 | 2.78 | 2.71 | 3.03 | 2.92 | -0.54 | Upgrade
|
| Buildings | 7.62 | 7.76 | 7.65 | 5.55 | - | - | Upgrade
|
| Machinery | 15.63 | 15.33 | 12.79 | 7.63 | 4.35 | 1.97 | Upgrade
|
| Construction In Progress | 0.65 | 0.36 | 0.26 | 0.18 | 0.34 | - | Upgrade
|
| Leasehold Improvements | 3.57 | 3.22 | 3.62 | 3.48 | 3.02 | 1.11 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.